Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|April 7, 2009
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapyLuca Castagna, Stefania Bramanti, Monica Balzarotti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 3, 2018
In Vitro Killing of Colorectal Carcinoma Cells by Autologous Activated NK Cells is Boosted by Anti-Epidermal Growth Factor Receptor-induced ADCC Regardless of RAS Mutation StatusIlaria Turin, Sara Delfanti, Federica Ferulli, et al.
Leukemia Research|February 1, 2011
Plerixafor and G-CSF for PBSC mobilization in patients with lymphoma who failed previous attempts with G-CSF and chemotherapy: a REL (Rete Ematologica Lombarda) experienceLuca Arcaini, Daniele Laszlo, Silvia Rizzi, et al.
Haematologica|February 19, 2026
Late-onset progressive multifocal leukoencephalopathy after teclistamab in multiple myeloma: extending the timeline of infectious riskDavide Chizzoniti, Fabrizio Ciambelli, Maria Luisa Latargia, et al.
International Journal of Cancer|August 29, 2020
Clinical presentation, diagnosis and management of therapy-related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly-ADP-ribose polymerase inhibitors: A single-center experienceElisabetta Todisco, Federica Gigli, Mara Mantiero, et al.
Cancer Reports (Hoboken, N.J.)|August 9, 2024
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid LeukemiaChiara Ronchini, Federica Gigli, Martina Fontanini, et al.
International Journal of Cancer|June 13, 2022
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomesElisabetta Todisco, Federica Gigli, Chiara Ronchini, et al.
Haematologica|May 21, 2026
Site-specific biology of tongue base aggressive B-cell lymphomas revealed by molecular subtype classificationDavide Chizzoniti, Caterina Cecchetti, Federica Melle, et al.
Transfusion|June 21, 2013
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphomaFrancesco Lanza, Roberto M Lemoli, Attilio Olivieri, et al.
Journal of Geriatric Oncology|October 24, 2020
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Pageof 5